이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Medley 관리

관리 기준 확인 1/4

Medley's CEO는 Kohei Takiguchi, Jun2009 에 임명되었습니다 의 임기는 15.08 년입니다. 는 ¥ 23.15B 가치에 해당하는 회사 주식의 19.82% 직접 소유합니다. 23.15B. 경영진과 이사회의 평균 재임 기간은 각각 1.4 년과 6.3 년입니다.

주요 정보

Kohei Takiguchi

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	15.3yrs
CEO 소유권	19.8%
경영진 평균 재임 기간	1.5yrs
이사회 평균 재임 기간	6.5yrs

최근 관리 업데이트

Recent updates

Medley, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 17

Industry Analysts Just Upgraded Their Medley, Inc. (TSE:4480) Revenue Forecasts By 10%

Feb 26

CEO

Kohei Takiguchi (40 yo)

15.3yrs

테뉴어

Mr. Kohei Takiguchi serves as President, Chief Executive Officer and Director at Medley,Inc. since June 2009. Prior to establishing Medley, he established Gemeinschaft, Inc. a U. S. corporation and became...

리더십 팀

이름	위치	테뉴어	보상	소유권
Kohei Takiguchi	CEO, President & Director	15.3yrs	데이터 없음	19.8% ¥ 24.7b
Ryo Kawahara	Senior VP & Head of Finance Division and CFO	8.2yrs	데이터 없음	0.99% ¥ 1.2b
Daiki Okiyama	VP and Head of Accounting & Tax and Finance Division	1.4yrs	데이터 없음	데이터 없음
Sho Imanaka	Senior Vice President	2.8yrs	데이터 없음	데이터 없음
Masaya Hakiri	Vice President and Head of Design & Communication	less than a year	데이터 없음	데이터 없음
Noriyoshi Owari	VP & Head of Corporate Development and Finance Division	1.4yrs	데이터 없음	데이터 없음
Hayato Inakawa	Vice President & Head of Human Capital Division	1.4yrs	데이터 없음	데이터 없음
Yosuke Ishizaki	Senior VP & Head of HR Platform Business	1.7yrs	데이터 없음	데이터 없음
Takayuki Nakamura	Senior VP & Head of Medical Platform Business	2.8yrs	데이터 없음	데이터 없음
Ryusuke Inamoto	VP & CTO of HR Platform Business	1.7yrs	데이터 없음	데이터 없음
Hiroyuki Komatsu	VP & President of Pacific Medical	1.3yrs	데이터 없음	데이터 없음
Hiromune Shishido	CTO of Medical Platform Business & VP	less than a year	데이터 없음	데이터 없음

1.5yrs

평균 재임 기간

경험이 풍부한 관리: 4480 의 관리팀은 경험 (평균 재직 기간 1.3 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Kohei Takiguchi	CEO, President & Director	15.3yrs	데이터 없음	19.8% ¥ 24.7b
Ryo Kawahara	Senior VP & Head of Finance Division and CFO	8.2yrs	데이터 없음	0.99% ¥ 1.2b
Noboru Kotani	Independent External Director	6.5yrs	데이터 없음	0.13% ¥ 161.1m
Ryoko Nagata	External Corporate Auditor	1.5yrs	데이터 없음	데이터 없음
Masahide Kamachi	External Corporate Auditor	7.5yrs	데이터 없음	0.035% ¥ 43.7m
Shohei Omote	Full Time Auditor	8.8yrs	데이터 없음	데이터 없음
Rina Sakuraba	Independent External Director	1.5yrs	데이터 없음	데이터 없음
Reiko Nagatsuma	Independent External Director	1.5yrs	데이터 없음	데이터 없음
Keisuke Hioki	Independent External Director	1.5yrs	데이터 없음	데이터 없음

6.5yrs

평균 재임 기간

44yo

평균 연령

경험이 풍부한 이사회: 4480 의 이사회는 경험(평균 재직 기간 6.3 년)으로 간주됩니다.

Medley 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Medley, Inc., Annual General Meeting, Mar 26, 2024

Medley, Inc., Annual General Meeting, Mar 29, 2023

Less than half of directors are independent

Less than half of directors are independent

Medley, Inc., Annual General Meeting, Mar 25, 2022

Recent updates

Medley, Inc. to Report Q3, 2024 Results on Nov 14, 2024

Investor sentiment deteriorates as stock falls 17%

Medley, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Medley, Inc.'s (TSE:4480) P/E Still Appears To Be Reasonable

Investor sentiment deteriorates as stock falls 23%

Investor sentiment improves as stock rises 18%

Medley, Inc. to Report Q2, 2024 Results on Aug 14, 2024

New minor risk - Share price stability

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Is Medley, Inc. (TSE:4480) Trading At A 30% Discount?

With Medley, Inc. (TSE:4480) It Looks Like You'll Get What You Pay For

Now 22% undervalued after recent price drop

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Medley (TSE:4480) Seems To Use Debt Rather Sparingly

Now 21% overvalued after recent price rise

Consensus EPS estimates increase by 11%

Medley, Inc. to Report Q1, 2024 Results on May 14, 2024

Industry Analysts Just Upgraded Their Medley, Inc. (TSE:4480) Revenue Forecasts By 10%

Consensus revenue estimates increase by 10%

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Now 23% overvalued after recent price rise

Medley, Inc., Annual General Meeting, Mar 26, 2024

Investor sentiment improves as stock rises 15%

Medley, Inc. to Report Fiscal Year 2023 Results on Feb 14, 2024

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Medley, Inc. (TSE:4480) agreed to acquire Lalune business of Ateam Wellness, K.K. for ¥500 million.

Consensus EPS estimates increase by 13%

Price target increased by 11% to JP¥6,625

Medley, Inc. to Report Q3, 2023 Results on Nov 14, 2023

Consensus EPS estimates increase by 23%

Price target increased by 24% to JP¥5,950

New minor risk - Earnings quality

Second quarter 2023 earnings released: EPS: JP¥47.30 (vs JP¥31.21 in 2Q 2022)

Consensus EPS estimates increase by 15%

Price target increased by 10% to JP¥4,950

Medley, Inc. (TSE:4480) agreed to acquire Gcm.Co.,Ltd.

Medley, Inc. to Report Q2, 2023 Results on Aug 14, 2023

Price target increased by 9.1% to JP¥4,800

Full year 2022 earnings: EPS exceeds analyst expectations

Full year 2022 earnings: EPS exceeds analyst expectations

Medley, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023

Consensus EPS estimates fall by 12%

Medley, Inc., Annual General Meeting, Mar 29, 2023

Medley, Inc. to Report Fiscal Year 2022 Results on Feb 14, 2023

Price target increased to JP¥4,500

Less than half of directors are independent

Third quarter 2022 earnings released: JP¥0.38 loss per share (vs JP¥5.33 loss in 3Q 2021)

Medley, Inc. Revises Consolidated Earnings Guidance for the Fiscal Ending December 31, 2022

Medley, Inc. (TSE:4480) agreed to acquire Tenxia, inc. from Masashi Okabe and Taishi Mitsuji and others for approximately ¥260 million.

Medley, Inc. (TSE:4480) acquired Tenxia.

Medley, Inc. to Report Q3, 2022 Results on Nov 11, 2022

Second quarter 2022 earnings released: EPS: JP¥31.21 (vs JP¥21.70 in 2Q 2021)

Medley, Inc. Provides Consolidated Earnings Guidance for the Fiscal Ending December 31, 2022

Medley, Inc. to Report Q2, 2022 Results on Aug 12, 2022

First quarter 2022 earnings: EPS exceeds analyst expectations

Medley, Inc. Provides Consolidated Earnings Guidance for the Fiscal Ending December 31, 2022

Price target decreased to JP¥3,950

Less than half of directors are independent

Medley, Inc. to Report Q1, 2022 Results on May 13, 2022

Full year 2021 earnings: EPS exceeds analyst expectations

Medley, Inc. Provides Consolidated Earning Guidance for the Year Ending December 31, 2022

Medley, Inc., Annual General Meeting, Mar 25, 2022

Price target decreased to JP¥4,250

Third quarter 2021 earnings released: JP¥5.33 loss per share (vs JP¥2.81 profit in 3Q 2020)

Consensus forecasts updated

Second quarter 2021 earnings released: EPS JP¥21.72 (vs JP¥2.81 in 2Q 2020)

Consensus EPS estimates increase to JP¥14.56

Medley, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2021

Medley, Inc. announced that it has received ¥5.13205 billion in funding from NTT DOCOMO, INC.